HSBC Holdings’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

HSBC Holdings’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,967	Closed	-$261K	–	3205
2020 Q3	$261K	Buy	+4,967	New	+$206K	﹤0.01%	2332
2020 Q1	–	Sell	-11,381	Closed	-$225K	–	3157
2019 Q4	$225K	Buy	+11,381	New	+$182K	﹤0.01%	2741
2019 Q2	–	Sell	-14,602	Closed	-$212K	–	2930
2019 Q1	$212K	Buy	+14,602	New	+$187K	﹤0.01%	2532
2017 Q1	–	Sell	-11,195	Closed	-$168K	–	2738
2016 Q4	$168K	Buy	+11,195	New	+$148K	﹤0.01%	2559

HSBC Holdings's MNTA Position: Q4 2020 in Review

HSBC Holdings sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 4,967 shares — an estimated $261K sold.

HSBC Holdings first reported a position in MNTA in Q4 2016 and held it in 4 quarters. The position peaked at $261K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

HSBC Holdings reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
HSBC Holdings sold 4,967 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $261K.
HSBC Holdings first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2016 and held it in 4 quarters.
HSBC Holdings's Momenta Pharmaceuticals, Inc. position peaked at $261K in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on HSBC Holdings's 13F filing for Q4 2020, filed 12 Feb 2021.